Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000994245 | SCV001147664 | pathogenic | not provided | 2016-10-01 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000994245 | SCV001574884 | pathogenic | not provided | 2021-11-14 | criteria provided, single submitter | clinical testing | This variant, c.13335_13347delinsCTTG, is a complex variant that results in the deletion of five and insertion of two amino acids in the USH2A protein (p.Glu4445_Ser4449delinsAspLeu) but otherwise preserves the integrity of the reading frame. Information on the frequency of this variant in the gnomAD database is not available, as this variant may be reported differently in the database. This variant has been observed in individuals with retinitis pigmentosa (PMID: 28041643, 30718709; Invitae). ClinVar contains an entry for this variant (Variation ID: 806350). This variant disrupts the p.Met4447 amino acid residue in USH2A. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29625443, 31872526, 31960602). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003455026 | SCV004181880 | pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing |